Kiora targets critical pathways underlying vision-threatening retinal diseases using innovative small molecules to slow, stop, or restore vision loss. We focus on conditions with limited or no effective …

Aug 8, 2025 · About Kiora Pharmaceuticals Kiora Pharmaceuticals is a clinical-stage biotechnology company developing advanced therapies for retinal disease.

Dec 29, 2025 · Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of ophthalmic diseases.

Jul 25, 2025 · Kiora Pharmaceuticals secures a U.S. patent for KIO-104, covering its use in treating ocular inflammation and related eye diseases.

Aug 13, 2025 · Kiora Pharmaceuticals (NASDAQ: KPRX) is a clinical-stage biopharmaceutical company developing advanced treatments for retinal disease. Our strategy is to target critical pathways …

Aug 7, 2025 · Kiora Pharmaceuticals Reports First Quarter Results; Initiating Two Phase 2 Trials for Treatment of Retinal Diseases; Cash and Short-term Investments Expected to Fund Operations into …

Kiora (kee-OR-ə) is a take on the Māori phrase, Kia ora, which means “have life” or “be healthy.” Ora also means “eye” in Latin. In essence, we are striving as a company to improve health through better …

Kiora Pharmaceuticals (NASDAQ: KPRX) is a clinical-stage biopharmaceutical company developing advanced treatments for retinal disease. Our strategy is to target critical pathways underlying eye …

Mar 31, 2024 · Kiora Pharmaceuticals is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. KIO-301 is being developed …

Kiora is a merfolk planeswalker who made her debut in Duels of the Planeswalkers 2012. [1] Kiora loves the seas, above all else, finding them beautiful and full of mysteries to discover. In a bid to protect …